Dementia

: 2022/03/10

Digital Health from a Healthcare Perspective (Part 4)

FRONTEO Aims to Develop the World's First Linguistic AI Medical Device

FRONTEO is developing a “conversational dementia diagnostic support AI program” that screens for cognitive dysfunction using AI and natural language. This program is the first linguistic AI program medical device in Japan, and clinical trials started in April 2021. Mr. Keisuke Harada, who has ten years of experience in pharmaceutical clinical development, will explain this AI program.

Mr. Keisuke Harada

: 2021/09/24

Psychiatry and the Potential of Digital Tools（Series ＃3）

Current Status of Digital Therapeutics for Mild Cognitive Impairment

The number of patients with Alzheimer's disease (AD) is increasing, and digital therapeutics (DTx) for AD treatment is the focus of much attention. In the U.S., there are some startups that are supported by colossal research funds for research on screening for mild cognitive impairment (MCI). Dr. Y will explain the future of MCI treatment and DTx from the perspective of an active psychiatrist.

Dr. Y

Digital Health
U.S. eHealth Journal

Vol. 92 (Issued at 2023/07/25)

ジャーナル92号のトピックは、Sky Labs (韓国発スマートリング)、DUOS (高齢者のSDoHアンメットニーズ)、Uber Health (OTC医薬品の配送)、Hyro (ChatGPT基盤のコールセンターサービス) など

Most Popular

1位

2位: LSMIP Editorial Office

3位: LSMIP Editorial Office

4位: LSMIP Editorial Office

5位: Internet Explorer - End Of Life

Press Room

Placeholder